Essex Investment Management’s AbbVie ABBV Stock Holding History

Essex Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,359	Closed	-$601K	–	475
2018 Q3	$601K	Buy	+6,359	New	+$603K	0.07%	283
2016 Q2	–	Sell	-81,460	Closed	-$4.65M	–	316
2016 Q1	$4.65M	Sell	81,460 -12,584	-13%	-$701K	0.8%	31
2015 Q4	$5.57M	Sell	94,044 -61,259	-39%	-$3.53M	0.87%	28
2015 Q3	$8.45M	Sell	155,303 -2,423	-2%	-$158K	1.39%	16
2015 Q2	$10.6M	Buy	157,726 +955	+0.6%	+$62.3K	1.6%	13
2015 Q1	$9.18M	Buy	156,771 +7,030	+5%	+$425K	1.28%	17
2014 Q4	$9.8M	Buy	149,741 +18,228	+14%	+$1.15M	1.43%	13
2014 Q3	$7.6M	Buy	131,513 +92,267	+235%	+$5.12M	1.16%	20
2014 Q2	$2.21M	Buy	+39,246	New	+$2.06M	0.33%	93

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Essex Investment Management's ABBV Position: Q4 2018 in Review

Essex Investment Management sold out of AbbVie (ABBV) in Q4 2018, closing a stake of 6,359 shares — an estimated $601K sold.

Essex Investment Management first reported a position in ABBV in Q2 2014 and held it in 9 quarters. The position peaked at $10.6M in Q2 2015. 2,063 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

Essex Investment Management reported no remaining AbbVie position as of Q4 2018 after selling out during the quarter.
Essex Investment Management sold 6,359 AbbVie shares in Q4 2018, an estimated $601K.
Essex Investment Management first reported a position in AbbVie in Q2 2014 and held it in 9 quarters.
Essex Investment Management's AbbVie position peaked at $10.6M in Q2 2015.
2,063 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.